Treatments

VIALE-A Trial Means New AML Treatments for Older Patients

The VIALE-A study is giving new hope to older patients with acute myeloid leukemia (AML).

Oral Drug Options for Relapsed AML Patients

Dr. Eunice Wang explains the oral drug options available to older AML patients and the importance of retesting when remission ends.

Andrew Schorr, Eunice Wang, MD

Latest News

Understanding Genetic Mutations and Immunotherapy for AML

Jessica Altman, MD

Consolidation Therapy and Stem Cell Transplants for AML

Elizabeth Bowhay-Carnes, MD

New Drug Options for Gene Mutations in Older AML Patients

Andrew Schorr, Jessica Altman, MD

I've Just Been Diagnosed With AML: What Comes Next?

Andrew Schorr, Courtney DiNardo, M.D., MSCE

Surge of New Treatments Gives Hope to AML Patients

Megan Trusdell

Early Palliative Care Reduces Anxiety and Depression in AML Treatment

AML Combined Therapies Are Changing Outcomes

William Donnellan, MD, Andrew Schorr

Therapies Making Treatment Possible for Older Patients

Amer Zeidan, MBBS, MHS, Eunice Wang, MD, Andrew Schorr

Immunotherapy for AML

Amer Zeidan, MBBS, MHS, Andrew Schorr

AML Frontline and Relapsed Setting Strategies

Hetty Carraway, MD, Andrew Schorr

New Oral Therapies Allow for Outpatient Care

Eunice Wang, MD, Uma Borate, MD, MS, Andrew Schorr

Understanding AML Treatment Phases

Pinkal Desai, MD, MPH, Andrew Schorr